Indiana
Indiana
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
In Your State
Economic Impact In Your State: Indiana
Economic Impact
$60.7B
Total output supported by biopharmaceutical sector
$2.8B
Tax Revenue Generated
133,291
Total Jobs
30,586
Direct Jobs
637
Total Clinical Trials
$183.5 million
Invested in Clinical Trials
12,125
Total Economic Impact of Clinical Trial Investments
$477.6 billion
Invested in Clinical Trials
Programs and Initiatives in Your State: Indiana
State programs and initiatives to promote biopharmaceutical industry development
- Accelerating Innovation, Commercialization & Entrepreneurial Development
- Building Advanced Manufacturing
- Building Research Capacity and/or R&D Infrastructure
- Economic Innovation Incentives
- STEM Education & Workforce Development
- Targeted Strategies
- Venture Financing
Programs and Initiatives
18
Patents per 1,000 people in Science & Engineering
Percentage of Workforce Employed in High-Tech Jobs
Related Resources
Research in Your Backyard
3,266 total clinical trials in Indiana